Canna Law Blog

JULY 16, 2024

In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA).

DEA 100

DEA Marijuana Topical Policy 100

Canna Law Blog

MAY 29, 2024

” As of a few days ago, DEA reiterated this position in response to an inquiry by attorney Shane Pennington, even going so far as to note “cannabis-derived THCA does not meet the definition of hemp under the [Controlled Substances Act] because upon conversion for identification purposes as required by Congress, it is equivalent to [THC].”

Hemp 71

Hemp DEA Seed-To-Sale THC 71

Canna Law Blog

FEBRUARY 16, 2024

Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.

DEA 85

DEA Seed-To-Sale Hemp Concentrates 85

Medicinal Genomics

JULY 13, 2023

one of just seven federally DEA- licensed cannabinoid research labs, had some encouraging news about how cannabinoids and cannaflavins can lengthen life spans while improving health spans. Watch Dr. Russo’s Presentation Hunter Land, Ph.D, the VP of Research & Development at Biopharmaceutical Research Company, Inc.,

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

The Blunt Truth

OCTOBER 24, 2019

The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Cannabis research was also a big topic. But there are some hiccups on the way to that big number.

Hemp 58

Hemp DEA CBD Topical 58

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. Virginia also legalized cannabis in 2021, but residents can expect to wait until 2024 before they can purchase cannabis products. More States Favor Cannabis Legalization.

Recreational 52

Recreational Data Cannabis DEA 52

Canna Law Blog

SEPTEMBER 4, 2024

Earlier this year, the DEA initiated rulemaking to reclassify cannabis as a schedule III narcotic. A lot of folks had hoped that cannabis would be rescheduled in advance of the 2024 election. Those hopes were dashed when the DEA scheduled a hearing for the proposed reclassification about a month after the election.

DEA 81

DEA Cannabis Legislation Topical 81